Skip to main content

Table 4 The relationship between the number or density of TILs with the prognosis of CCA

From: The role of tumor-infiltrating lymphocytes in cholangiocarcinoma

Ref

Author

Year

Country

Sample(n)

Location of TILs

Subtype of TILs

Assessment Of TILs

Criteria for cut-off (Positive/High Expression)

Follow-up (months)

Endpoint

Prognostic significance

[17]

Asahi Y

2020

Japan

iCCA (78)

IT / PT

CD8+ / Foxp3+

IHC

Mean (cell count, ×400 HPF)

Not reported

OS

Only a high CD8+ count in the PT area are associated with better OS (p=0.0103), other subtypes and locations are not associated with prognosis.

[23]

Lu JC

2019

China

iCCA (320)

IT / PT

PD1(+)T

IHC

Score>3 (5%–9% of the tissue section)

Not reported

OS / RRS

High PD1(+) T cells in ICC patients with HBV infection are associated with inferior OS (p =0.026) and a higher RRS (p=0.011).

[27]

Ueno T

2018

Japan

eCCA (117)

IT

CD4+ / CD8+ / Foxp3+

IHC

Median (cell count, ×400 HPF)

27 (median)

OS

High numbers of CD4+ TILs are related to better OS (p=0.049).

[22]

Kitano Y

2018

Japan

eCCA (114)

IT

CD8+ / Foxp3+

IHC

Mean (cell count, ×400 HPF)

62.6 (median)

OS

Low CD8 count and high number of Tregs are associated with worse OS (p=0.04, 0.02).

[21]

Kim R

2018

USA

eCCA (44)

IT

CD8+CD45RO+

IHC

≥100 (cell counts, ×400 HPF)

Not reported

OS

Individuals with CD8+CD45RO+ TILs displayed a longer OS (p=0.013).

[28]

Vigano L

2019

Italy

iCCA (43)

IT

CD3+ / CD8+ / Foxp3+

IHC

>0.10% (rate of positive cell staining, 400 HPF)

42 (median)

OS / RFS

CD3+ and CD8+ infiltrate is associated with longer OS (p=0.001, 0.051) and lower RRS (p=0.01, p=0.004), while Foxp3+ infiltrate is associated with shorter OS (p=0.049).

[18]

Goeppert B

2013

Germany

eCCA (149) iCCA (157) GBCA (69)

IT / PT

CD4+ / CD8+ / Foxp3+ / CD20+

IHC

median (cell count, ×400 HPF)

Not reported

OS

Patients with intraepithelial tumor-infiltrating CD4+ and CD8+, show a significantly longer OS (p=0.002, p=0.015). Presence of CD20+ and Foxp3+ T lymphocytes also has a positive prognostic impact (p=0.032, p=0.018).

[25]

Oshikiri T

2003

Japan

eCCA (58)

IT

CD8+

IHC

>0 (positive cell count, x200 HPF)

Not reported

OS

Intratumoral CD8+T cells are associated with increased OS (p =0.0001).

[24]

Miura T

2017

Japan

iCCA (115)

IT

CD8+

IHC

median (cell count, ×400 HPF)

38 (median)

OS

CD8+T cells in cancer cell nests is not related to OS (p=0.365).

[19]

Hasita H

2010

Japan

iCCA (55)

IT

Foxp3+

IHC

median (cell count, ×400 HPF)

39.7 (mean)

OS / DFS

Count of Foxp3+ is not correlated with DFS and OS (p=0.09, p=0.23).

[30]

Xu YP

2021

China

iCCA (140)

IT

CD8+

IHC

Median (cell count, x400 HPF)

25 (median)

OS / DFS

High count of infiltrating CD8+ cells is related to longer OS and DFS.

[26]

Tian L

2020

China

iCCA (322)

IT

CD8+

mIHC

Median (cell count, x400 HPF)

27 (median)

OS / TTR

Patients with a high density of CD8+ T cells displayed longer OS (p=0.006) and more favorable TTR (p=0.003)

[29]

Wu H

2021

China

iCCA (50)

IT / TM

CD8+

IHC

Median (cell count, x200 HPF)

26.5 (median)

OS / RPF

A higher number of CD8+ cells in the tumor margin is associated with prolonged OS and RFS (p=0.048, p=0.033).

[20]

Kim H

2021

Korea

CCA (52)

IT / TM

FoxP3-CD4+

mIHC

Median (cell count, x400 HPF)

Not reported

OS / RFS

A high density of FoxP3-CD4+ cells in the tumor margin is independently associated with favorable DFS and OS (p=0.005, p=0.004).

  1. Various studies reported oncological outcome with respect to tumor-infiltrating lymphocytes in cholangiocarcinoma
  2. CCA cholangiocarcinoma, DFS disease free survival, eCCA extrahepatic cholangiocarcinoma, FOXP3 forkhead box P3, GBAC gallbladder cancer, HPF high power field, iCCA intrahepatic cholangiocarcinoma, IT intratumoral, PT peritumoral, Ref reference, RFS relapse-free survival, RRS recurrence rate, TIL tumor-infiltrating lymphocytes, TM tumor margin